Ferroptosis Inhibitor Screening in HT-1080 Cells
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : Columbia University, New York University, University of Pittsburgh, Retrotope (United States), National Academy of Sciences of Belarus, Belarusian State University
Variable analysis
- 100 μM α-Tocopherol
- 1 μM of RSL3
- 10 μM of Erastin
- 5 μM of FIN56
- 10 μM of FINO2
- Vehicle
- Protein expression levels of GPX4, Ferritin Light Chain, IRP2, Transferrin receptor 1 (CD71, TFRC), Actin, alpha-tubulin and GAPDH
- 0.8 million HT-1080 cells seeded per well in a 60 mm plate
- Cells allowed to adhere overnight
- Co-treatment duration of 10 h
- Cell harvesting with trypsin (Invitrogen, #25200-114)
- Cell pellet freezing at -80°C
- Cell pellet thawing, lysis, and blotting
- Positive control: Not specified
- Negative control: Vehicle treatment
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!